Embecta Corp. (EMBC) stock
EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3080% below fair value
$6.09−0.06 (-0.98%)
Close on Nov 18, 2026Market cap $345.06MP/E 4.1Yield 9.85%
Embecta shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Embecta's shares outstanding was 59M at Jun 30, 2026. For fiscal 2025 it was 59M, up 1.0% from the year before. The highest annual figure on record is 59M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 59M | +1.0% |
| FY2024 | Sep 30, 2024 | 58M | +1.0% |
| FY2023 | Sep 30, 2023 | 58M | +0.5% |
| FY2022 | Sep 30, 2022 | 57M | +0.8% |
| FY2021 | Sep 30, 2021 | 57M | 0.0% |
| FY2020 | Sep 30, 2020 | 57M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | 59M | +0.0% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | 59M | +1.3% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | 59M | +1.1% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | 59M | +1.1% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | 58M | +1.1% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | 59M | +1.3% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | 59M | +1.7% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | 59M | +1.7% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | 58M | +0.5% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | 58M | +0.5% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | 58M | +0.3% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | 58M | +4.8% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | 58M | -1.1% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | 58M | -0.5% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | 57M | +0.8% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | 55M | +1.1% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | 58M | +0.7% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | 58M | +0.0% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | 57M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | 55M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | 58M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | 58M | – |
See a number that looks wrong?